Primary progressive aphasia (PPA) encompasses the three subtypes nonfluent/agrammatic variant PPA, semantic variant PPA, and the logopenic variant PPA, which are characterized by distinct patterns of language difficulties and regional brain atrophy. To validate the potential of structural magnetic resonance imaging data for early individual diagnosis, we used support vector machine classification on grey matter density maps obtained by voxel-based morphometry analysis to discriminate PPA subtypes (44 patients: 16 nonfluent/agrammatic variant PPA, 17 semantic variant PPA, 11 logopenic variant PPA) from 20 healthy controls (matched for sample size, age, and gender) in the cohort of the multi-center study of the German consortium for frontotemporal lobar degeneration. Here, we compared a wholebrain with a meta-analysis-based disease-specific regions-of-interest approach for support vector machine classification. We also used support vector machine classification to discriminate the three PPA subtypes from each other. Whole brain support vector machine classification enabled a very high accuracy between 91-97% for identifying specific PPA subtypes vs. healthy controls, and 78/95% for the discrimination between semantic variant vs. nonfluent/agrammatic or logopenic PPA variants. Only for the discrimination between nonfluent/agrammatic and logopenic PPA variants accuracy was low with 55%. Interestingly, the regions that contributed the most to the support vector machine classification of patients corresponded largely to the regions that were atrophic in these patients as revealed by group comparisons. Although the whole brain approach took also into account regions that were not covered in the regions-of-interest approach, both approaches showed similar accuracies due to the disease-specificity of the selected networks. Conclusion, support vector machine classification of multi-center structural magnetic resonance imaging data enables prediction of PPA subtypes with a very high accuracy paving the road for its application in clinical settings.
Introduction
Primary progressive aphasia (PPA) is a neurodegenerative disease with insidious onset mainly characterized by a language dysfunction that remains isolated for at least two years without significant impairment in other cognitive domains (Gorno-Tempini et al., 2011; Mesulam, 1982; Neary et al., 1998) . PPA subsumes three gradually progressive language disorders, namely semantic variant PPA (svPPA) or semantic dementia, nonfluent/agrammatic variant PPA (nfvPPA) or progressive nonfluent aphasia, and logopenic variant PPA (lvPPA) or logopenic progressive aphasia (Gorno-Tempini et al., 2008; Gorno-Tempini et al., 2004; Gorno-Tempini et al., 2011) . SvPPA is mainly characterized by impairments in confrontation naming, single-word comprehension, and object-knowledge, as well as surface dyslexia or dysgraphia (Gorno-Tempini et al., 2011) . The imaging supported diagnosis of svPPA is given when patients additionally show atrophy and/or hypometabolism in the anterior (ventral and lateral) temporal lobe. Patients suffering from nfvPPA show predominantly agrammatism, effortful halting speech with inconsistent speech sound errors and distortions (apraxia of speech), and impaired comprehension of syntactically complex sentences. These language deficits are often associated with atrophy or hypometabolism in left inferior frontal gyrus, insula, premotor, and supplementary motor areas. LvPPA is characterized by impaired single-word retrieval in spontaneous speech and naming as well as impaired repetition of sentences. Patients suffering from lvPPA furthermore often show phonologic paraphasias in spontaneous speech and naming. The imaging supported diagnosis of lvPPA is given when patients additionally show atrophy and/or hypometabolism in left posterior parietal, supramarginal, and angular gyri (Gorno-Tempini et al., 2011) . The suggested imaging criteria have recently been validated by comprehensive meta-analyses (Bisenius et al., 2016) .
The prevalence of PPA is roughly estimated to range from 3-15/100,000 in the US population (Grossman, 2010; Harvey et al., 2003; Ratnavalli et al., 2002) . PPA is thus a rare disease, which makes it very difficult for neurologists outside specialized clinics to correctly recognize and differentiate between the three PPA variants in routine hospital practice (e.g., Wilson et al., 2009) . Given that the
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A C C E P T E D M A N U S C R I P T SVM classification for PPA S. Bisenius et al. 4 current imaging criteria are only supportive for the diagnosis of PPA, magnetic resonance imaging (MRI) scans are often not included as standard in the clinical assessment of PPA, but mainly used to exclude differential diagnoses (e.g., Wilson et al., 2009) . It has been shown for other types of dementia like for instance, AD that changes in atrophy as visualized by MRI are an especially good biomarker for correct early diagnosis and furthermore even predictive for individuals with mild cognitive impairment to decline into AD (e.g., Frisoni et al., 2010; McEvoy and Brewer, 2010; Schroeter et al., 2009; . Therefore, it might be highly interesting to investigate whether MRI scans have a similar predictive value for the correct early diagnosis of PPA and to investigate which brain regions contribute the most to the classification of its three variants.
On the one hand, it seems plausible that brain regions proposed in the current diagnostic imaging criteria and based on a large range of imaging studies (Bisenius et al., 2016; Gorno-Tempini et al., 2011) enable the correct diagnosis of the three PPA variants. On the other hand, most of the current imaging studies report comparisons of the three variants of PPA with age-matched healthy controls at a group-level and it has been critically discussed that statistical differences at group level might not necessarily reveal the most important regions to correctly diagnose individual cases (Davatzikos et al., 2008a; Davatzikos et al., 2008b; Wilson et al., 2009) . Therefore, it might advance our knowledge in this field crucially to investigate whether brain regions contributing the most to the correct diagnosis of the three PPA variants indeed correspond to regions that are especially atrophied in these three variants.
Moreover, it might be highly interesting to explore whether disease-specific regions of interest (ROIs) in comparison with whole brain approaches even enhance the predictive power of MRI scans for the correct PPA classification.
To address these issues, we investigated here atrophy, namely changes in grey matter density, with voxel-based morphometry (VBM) in patients suffering from one of the PPA variants in comparison with healthy controls as well as by comparing patients with different PPA variants at a group level.
Subsequently, we used linear support vector machine (SVM) classification of the individual grey matter
SVM classification for PPA S. Bisenius et al. 5 density maps to investigate their discriminative or predictive power for the correct classification of single subjects as belonging to one of the PPA variants or healthy controls. A number of recent studies have used similar pattern classification methods to classify patients with AD, FTD, and mild cognitive impairment (Davatzikos et al., 2008a; Davatzikos et al., 2008b; Dukart et al., 2013; Dukart et al., 2011; Fan et al., 2008; Klöppel et al., 2008b; Lerch et al., 2008; Misra et al., 2009; Teipel et al., 2007; Vemuri et al., 2008) . Wilson and colleagues (2009) investigated the utility of structural MRI scans for SVM classification in PPA variants in a single center study. Here, we investigated patients included in the multi-center study of the German consortium for frontotemporal lobar degeneration (FTLD; Otto et al., 2011) to replicate and generalize previously reported results, where the multi-center design is a precondition for application in clinical routine in the future. Additionally, we compared a whole-brain approach to a disease-specific ROI approach based on comprehensive anatomical likelihood estimation meta-analyses on the three variants of PPA (Bisenius et al., 2016) . These ROIs represent the prototypical networks consistently affected in the three variants of PPA across MRI studies reporting group-level statistics. Note that these ROIs are based on a totally different cohort avoiding circularity. In order to better understand possible differences between the whole brain and the regionsof-interest approach, we furthermore computed and visualized the voxels that contributed the most to the SVM classification in the whole brain approach. To reveal whether the brain regions that contributed the most to the SVM classification in the whole brain approach corresponded to the regions that were especially atrophic in the three PPA variants, we also report pairwise group-level comparisons of grey matter probability maps between patients and healthy controls, respectively between PPA variants. For the pairwise group-level comparisons, we hypothesized that, according to the current imaging criteria and previously published VBM studies, atrophy is focused to left frontoinsular regions in nfvPPA, to the (mainly left) anterior temporal lobe in svPPA, and to the (predominantly left) posterior perisylvian or parietal cortex in lvPPA (e.g., Bisenius et al., 2016; Desgranges et al., 2007; Gorno-Tempini et al., 2011; Mummery et al., 2000) .
Furthermore, we hypothesized that the same brain regions would mainly contribute to the correct SVM
A C C E P T E D M A N U S C R I P T SVM classification for PPA S. Bisenius et al. 6 classification in PPA variants and healthy controls and that disease-specific ROI approaches would reveal a higher predictive power for the SVM classification than whole-brain approaches.
Materials and methods

Subjects
Patients and healthy controls were recruited within seven centers (located in Ulm, Munich, Leipzig, Homburg, Erlangen, Bonn, and Goettingen) of the German consortium for FTLD (http://www.ftld.de).
All subjects gave written consent. The research protocol was in accordance with the latest version of the Declaration of Helsinki and approved by the universities' ethics committees. For each center, the clinical evaluation and the assessment of the MRI scans were done on site according to standard operating procedures. That is, all of these centers used the same study protocol (diagnostic criteria, demographic, neuropsychological and language assessment, and scanning parameters), except for one center, where different scanning parameters were used (see section 2.2). The diagnosis of PPA required progressive deterioration of speech and that the main deficits were restricted to speech and language for at least two years. Patients were diagnosed more specifically with nfvPPA, svPPA, or lvPPA according to the newest diagnostic criteria (Gorno-Tempini et al., 2011) . Note that data from the patient's first visit in the multi-centric FTLD consortium's study was included guaranteeing the relevance of our results for early diagnosis of PPA syndromes. None of the patients included in this study had any comorbid psychiatric or neurodegenerative disease. The degree of clinical impairment of the patients was assessed using the Clinical Dementia Rating scale (CDR) and the FTLD-modified 
Image acquisition
All structural images were acquired on Siemens Magnetom 3T scanners (2xVerio, 2xSkyra, 2xTrio, 1xAllegra, Erlangen, Germany). 47 T1-weighted images (12 svPPA, 11 nfvPPA, ten lvPPA, 14 healthy controls) were acquired using a magnetization prepared rapid gradient echo sequence with a matrix=240x256x176, resolution=1x1x1 mm, field of view=240 mm, repetition time=2300 ms, echo time=2.98 ms, inversion time=900 ms, and flip angle=9°. For 17 subjects (five nfvPPA, five svPPA, one lvPPA, six healthy controls), T1-weighted images were acquired using a magnetization prepared rapid gradient echo sequence with a matrix=208x256x256, resolution=1x1x1 mm, field of view=256 mm, repetition time=2200 ms, echo time=4.38 ms, inversion time=1200 ms, and flip angle=8°. The distribution of the two sequences (scanning parameters) did not differ significantly, neither between patient groups nor between patient groups and healthy control groups (see Table 1 ). The very first MRI scans that were assessed as soon as the subjects were enrolled in the study, were used for analyses.
Data analysis
Clinical characteristics
We used SPSS version 22 (IBM Corporation, Armonk, NY) to compute descriptive group scores (mean and standard deviation) for the overall patient and healthy control groups as well as for the respective subsets after matching for sample size, age, gender, and scanning parameters. Group comparisons for age, disease duration, education, and total grey matter density between all patient and healthy control groups as well as between PPA variants were performed using one-way ANOVAs, Kruskal-Wallis tests, and post-hoc t-tests in SPSS. Group comparisons for demographic and clinical characteristics between the matched subsets were performed using independent t tests (normally distributed data)
and Mann-Whitney U tests (not normally distributed data) in SPSS. Group comparisons for gender and scanning parameter were done using chi-square tests in SPSS.
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A C C E P T E D M A N U S C R I P T (Smith and Nichols, 2009; Winkler et al., 2014) . Age, gender, and total grey matter were entered as covariates in the general linear model and results are reported at a family-wise error (FWE) corrected p < 0.05.
SVM classification (Vapnik, 1995; Vapnik, 1998) was performed using libsvm version 3.18 (Chang and Lin, 2001; https://www.csie.ntu.edu.tw/~cjlin/libsvm) in a MATLAB 8.5 environment (Mathworks, Inc., Sherbon, MA, USA). Analyses were done using a linear kernel and the default solver C-SVC with C=1.
In SVM classification, an optimal separating hyperplane is defined, which maximizes the distance between subjects belonging to different groups. In the training step, SVM assigns a weight to the scan of each subject which indicates its importance for the discrimination between groups. This weight is multiplied by a label vector which indicates the group of the scan (e.g., patient or healthy control). The cross-validation of the trained SVM was performed using the leave-one (subject)-out method. This procedure iteratively leaves-out the information of one subject of each group and trains the model on the remaining subjects for subsequent class assignment of the respective subject that was not
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SVM classification for PPA S. Bisenius et al. 9 included in the training procedure. This validation method allows the generalization of the trained SVM to data that have not been presented to the SVM algorithm previously and avoids the danger of inflating accuracies
In the whole brain approach, we included all voxels that had a probability for grey matter higher than 0.2 (because voxels lying between white matter and ventricular cerebrospinal fluid tend to be misclassified as grey matter (e.g., Ashburner and Friston, 2000; Dukart et al., 2011) . In the ROI approach, we used the results from a recently published anatomical likelihood estimation metaanalysis on the three variants of PPA (p < 0.05 false discovery rate corrected) across MRI studies as a prototypical disease-specific template (Bisenius et al., 2016) . The original meta-analytic clusters were coregistered to the Montreal Neurological Institute template of the VBM results using SPM 8 and dilated by two voxels using the 3 D dilation function implemented in the WFU PickAtlas (Maldjian, http://www.nitrc.org/projects/wfu_pickatlas). Non-parametric statistical comparisons were calculated between the performance (as indicated by the area under the receiver operating characteristic curve, AUC) of the ROI approach and the whole brain approach for all pairwise comparisons at p<0.05 in StAR (Vergara et al., 2008; www.melolab.org/star/home.php).
In order to determine and visualize the importance of each voxel for the discrimination between groups in the whole brain approach, we multiplied each grey matter probability map (containing only voxels where p > 0.2) by the product of weight and label and summed on a voxel basis (Klöppel et al., 2008b) .
Results
Demographic and clinical characteristics
The demographic and clinical characteristics of the overall patient and healthy control groups are shown in Table 1 . The patient and healthy control groups did not differ significantly from each other in age, education, or disease duration. The patient and healthy control groups differed however A detailed description of each of the pairwise comparisons between the matched subsets is given in Supplementary additionally differed significantly from healthy controls in the Repeat and Point Test. In the pairwise comparisons between PPA variants, svPPA showed a significantly lower test score in the Point task than nfvPPA and a significantly higher test score in the Repeat task than lvPPA (see Supplementary   Table A .1).
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Voxel-based morphometry results
Significant results of the statistical comparison between grey matter density maps of healthy controls and patients are shown in red (nfvPPA), light green (svPPA), and blue (lvPPA) color in Figures 1-3 on the top left (for more details, see Supplementary Table A .2). All results are reported at an FWE corrected significance level of p < 0.05. The results of the statistical comparison between grey matter density maps of svPPA and nfvPPA are shown in Figure 4 on the top left (svPPA < nfvPPA in light green color, nfvPPA < svPPA in red color). The results for the statistical comparison between lvPPA and svPPA are shown in Figure 5 on the top left (svPPA < lvPPA in light green color, lvPPA < svPPA no significant results at p < 0.05). There were no significant results for the comparison between lvPPA and nfvPPA at a FWE corrected significance level of p < 0.05 (therefore not shown). More details on the pairwise comparisons between PPA variants are given in Supplementary Table A. 2.
Support vector machine classification results
SVM classification was applied separately to each group comparison: 1) nfvPPA vs. healthy controls, 
Group comparisons between patients and healthy controls
The accuracy for the classification between different variants and healthy controls using the leave-oneout approach ranged from 91 to 97 % for the whole brain approach and from 82 to 100 % for the ROI approach. Details on the respective sensitivity, specificity, and accuracy are given in Figures 1-3 Here, values range between -1 and 0 or 0 and 1 and reflect the relative importance of these voxels in the discrimination between both groups. Voxels that contributed the most to the classification of subjects as patients (i.e., had a higher negative value) are depicted in yellow and the voxels that contributed the most to the classification of subjects as healthy controls (i.e., had a higher positive value) are shown in light green. A value near 0 indicates that this voxel was neither indicative for the classification as patient nor as healthy control.
Brain regions that contributed the most to the classification of subjects as nfvPPA vs. control subjects ( Figure 1 on the 
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A Regions that contributed the most to the classification of subjects as svPPA vs. control subjects included bilaterally (although predominantly in the left hemisphere) cerebellum, inferior, middle and superior temporal gyri, middle occipital gyrus, parahippocampal gyrus, hippocampus, amygdala, putamen, insula, precentral and postcentral gyri, middle frontal gyrus, inferior parietal gyrus, and cingulate gyrus (see Figure 2 on the top right). Classification accuracy was very high for both approaches (97 % for the whole brain approach and 100 % for the ROI approach). The statistical comparison between approaches showed very high AUC values for both, but without significant differences (AUC ROI =1.00, AUC whole brain =0.97, p=0.32). Regions that contributed the most to the classification of subjects as lvPPA patients vs. control subjects are shown in yellow in Figure 3 on Note that the scale of the distance weights has no applicable units. Bottom: Sensitivity, specificity, and accuracy for the ROI approach and the whole brain approach in SVM classification. Note that the scale of the distance weights has no applicable units. Bottom: Sensitivity, specificity, and accuracy for the ROI approach and the whole brain approach in SVM classification. Figure 5 illustrates on top right in yellow the regions that contributed the most to the classification as lvPPA and in green the regions that contributed the most to the classification as svPPA. Sensitivity refers to the ratio of correctly classified lvPPA patients and specificity to the ratio of correctly classified svPPA patients. Positive and negative predictive values are given in Supplementary Table A with 55 % for the whole brain approach and higher with 64 % for the ROI approach. AUC values were comparable, namely higher for the ROI than the whole brain approach, but without significant differences between them (AUC ROI =0.64, AUC whole brain =0.59, p=0.50). 
Group comparisons between PPA variants
Discussion
To our knowledge, this is the first study demonstrating that SVM classification in multi-center MRI data can be used to diagnose and dissociate PPA subtypes, where the multi-center design is a precondition for application in clinical routine in the future. Moreover, we compare a whole brain vs. data-driven disease-specific ROI approach for SVM classification. We used ROIs reported in a recent comprehensive meta-analysis on PPA (Bisenius et al., 2016) . In order to reveal whether the regions that contributed the most to the whole brain SVM classification of the three variants of PPA corresponded to the regions that were especially atrophic in the respective variant, we additionally conducted statistical group-level comparisons between patient groups and healthy control groups. In the following, we are going to introduce the results of these group-level comparisons, before we discuss in more detail the results of the SVM classification for the whole brain approach and the ROI approach as well as possible further implications.
Atrophy in the different variants of primary progressive aphasia
The group comparisons in our study revealed regional brain atrophy that included the disease-specific brain areas identified in comprehensive systematic and quantitative meta-analyses across imaging studies from the literature, if one compares this data for each PPA variant (see left top and bottom images in Figures 1-3) . Beyond that our group-level comparisons are in line with studies showing that, with the progression of the disease, the atrophic networks in the three subtypes of PPA partly converge (e.g., Gorno-Tempini et al., 2011; Rogalski et al., 2011) . Mild and early svPPA has been shown to involve atrophy in (predominantly left) anterior temporal lobe, with extension to the adjacent temporoparietal junction, hippocampus and amygdala and posterior orbital cortex as well as in the right anterior temporal lobe (Czarnecki et al., 2008; Grossman, 2010 Krueger et al., 2010 Mesulam et al., 2012; Rohrer et al., 2008) and to progress bilaterally into posterior and superior temporal lobe, left temporoparietal junction, bilateral cingulate cortex and orbitofrontal gyri, left superior orbitofrontal gyrus, left inferior and superior frontal gyri (e.g., Grossman, 2010; Kumfor et al., 2016; Rogalski et al., 
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SVM classification for PPA S. Bisenius et al. 20 2011) . Early and mild stages of nfvPPA, on the other hand, have been shown to be characterized by atrophy in left inferior frontal gyrus, temporoparietal junction, anterior superior temporal gyrus, posterior middle frontal gyrus and precentral gyrus (Mesulam et al., 2012) and to progress into left anterior temporal lobe, orbital cortex, dorsolateral prefrontal cortex, anterior cingulate cortex, and along the perisylvian fissure into the parietal lobe (e.g., Grossman 2010; Rogalski et al., 2011) . For lvPPA, atrophy has been shown to progress from (predominantly left) posterior superior temporal cortex, inferior parietal cortex, posterior cingulate cortex and medial temporal cortex into the anterior and lateral temporal cortex, caudate nucleus, insula, inferior frontal gyrus and dorsal frontal cortex as well as into the temporo-parietal junction, posterior cingulate and precuneus of the right hemisphere. (e.g., Rogalski et al., 2011; Rohrer et al., 2013) .
Support vector machine classification is a useful tool to differentiate between healthy controls and primary progressive aphasia variants
Accuracies for the whole brain approach in SVM classification between patients and healthy controls ranged from 91 % for nfvPPA over 95 % for lvPPA to 97 % for svPPA. The between-subtype whole brain SVM classification enabled high accuracy of 78 and 95 % for the discrimination between svPPA vs. nfvPPA and svPPA vs. lvPPA variant. Only for the discrimination between nfvPPA and lvPPA variants accuracy was low with 55%. These numbers are in line with previously reported accuracies ranging from 58-100 % in studies on neurodegenerative diseases like AD (e.g., (e.g., Chetelat and Baron, 2003; Davatzikos et al., 2008b; Dukart et al., 2013; Dukart et al., 2011; Klöppel et al., 2008b; Lerch et al., 2008; Teipel et al., 2007; Vemuri et al., 2008) , mild cognitive impairment (e.g., Davatzikos et al., 2008a; Teipel et al., 2007) , FTD (e.g., Davatzikos et al., 2008b; Dukart et al., 2011; Klöppel et al., 2008a) , and PPA (Wilson et al., 2009; Zhang et al., 2013) .
Until now, there has only been one study investigating the three variants of PPA with SVM classification (Wilson et al., 2009) . These authors performed a principal component analysis on MRI scans from one study center and subsequently used the results for the pairwise SVM classification
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SVM classification for PPA S. Bisenius et al. 21 between patients and healthy controls as well as between the three patient groups. Wilson et al. (2009) found an accuracy of 100 % for the discrimination between svPPA patients and healthy controls, 100 % for the classification between lvPPA patients and healthy controls, and an accuracy of 89 % for the discrimination between nfvPPA and healthy controls. These authors report an accuracy of 89 % for the discrimination between svPPA and nfvPPA patients, 93.8 % for svPPA vs. lvPPA, and 81.3 % for lvPPA vs. nfvPPA. Our SVM results using the whole brain approach on grey matter density maps in the multi-center cohort of the FTLD consortium are thus comparable with the results of Wilson et al.
(2009) with regard to the classification between patients and healthy controls showing higher accuracies for svPPA and lvPPA than for nfvPPA and the classification between lvPPA and nfvPPA showing a lower classification accuracy than the other classifications between PPA variants.
Additionally, we performed group-level comparisons on the grey matter density maps between patients and healthy controls as well as between PPA variants in order to investigate whether the regions that contributed the most to the SVM classification of patients also corresponded to the regions mostly atrophied in these patients. Figures 2 and 3 show that brain regions that were most consistently atrophied in svPPA and lvPPA indeed also contributed the most to the SVM classification of these patients. For nfvPPA, on the other hand, brain regions that contributed the most to the SVM classification as patients were not constrained to the regions that were atrophied in our nfvPPA patients, but also encompassed very similar regions in the contralateral (right) hemisphere (see Figure   1 ). A possible explanation for the importance of the additional brain regions in the right hemisphere might be that they were affected to a lesser extent (and thus not significant in the group-level comparison) and that SVM classification as a more sensitive method already took into account early atrophy in these regions. There is a general consensus that the results of group-level statistics might not be applicable to individual scans, because their sensitivity and specificity at early stages of brain pathology is insufficient for the prediction of the status of individual scans (Davatzikos et al., 2008b; Fan et al., 2008; Wilson et al., 2009 ).
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
SVM classification for PPA S. Bisenius et al. 22 Interestingly, for the discrimination between svPPA and nfvPPA, the regions that contributed to the SVM classification as svPPA patients (see Figure 4 on the top), corresponded to the regions that were most consistently atrophied in these patients (see Figure 2 on the top left). The regions that contributed to the SVM classification as nfvPPA, on the other hand, were (except for two characteristic regions in the inferior and middle frontal gyri) rather spread. This might be due to the fact that the group comparisons between patients and healthy controls showed for both, svPPA and nfvPPA, significant atrophy in the superior temporal gyrus, parahippocampal area, hippocampus, insula, and inferior frontal gyrus (see Figures 1 and 2 on the top left) . Although atrophy in the superior temporal gyrus, parahippocampal area, and hippocampus have been discussed to be rather specific for svPPA, while insula, and inferior frontal gyrus have been discussed to be rather characteristic for nfvPPA, it has been shown in longitudinal studies that with the progression of the disease, the atrophic networks in the three variants of PPA partly converge (e.g., Gorno-Tempini et al., 2011; Rogalski et al., 2011) .
Given that on the one hand several regions might be affected similarly in nfvPPA and svPPA depending upon the current stage of the respective disease and on the other hand structural MRI scans do not provide any information regarding the temporal dynamic pattern of brain atrophy, the SVM classification method, given its high sensitivity, might not always be able to perfectly discriminate between these two variants. For both subtype-specific classifications, svPPA vs. nfvPPA and svPPA vs. lvPPA, we reached a high classification accuracy, although the number of patients was rather low for lvPPA and the respective comparison. The high accuracy might be related to a relatively strong (in the sense of high t-values) and regionally focused atrophy in svPPA. This is obvious in the group comparisons revealing much higher atrophy in svPPA than nfvPPA or lvPPA, whereas nfvPPA showed stronger atrophy only in a very small area and lvPPA did not show any atrophy in comparison with svPPA. Note that disease duration and severity did generally not significantly differ between PPA subtypes excluding these factors as explanation for differences in classification accuracy.
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SVM classification for PPA S. Bisenius et al. 23 As stated before the whole-brain SVM classification between nfvPPA and lvPPA variants reached only a low accuracy. This might be related to relatively small and rather distributed atrophy in these two PPA variants or to conceptual issues. In a prospective data-driven study, Sajjadi et al. (2012) examined to which extent PPA patients would be classifiable according to the revised clinical diagnostic criteria and which linguistic impairments would cluster together (and thus form distinct syndromes) using principal factor analysis. In this cohort, 58.7 % of the patients could be assigned to one of the three variants of PPA proposed by Gorno-Tempini et al. (2011) , while 41.3 % of the patients were classified as mixed PPA because their deficits either extended beyond a single PPA variant or they met the diagnostic criteria for more than one variant. The principal factor analysis identified two clear syndromes corresponding to the proposed syndromes of svPPA and nfvPPA as well as a residual miscellany. Interestingly, impaired sentence repetition, which has been proposed as a cardinal diagnostic feature for lvPPA, aligned with the factor corresponding to nfvPPA. One might therefore speculate that low classification accuracy between nfvPPA and lvPPA in imaging data might not only be related to the rather relatively small and distributed atrophy, but possibly also to problems in clinically distinguishing both PPA syndromes.
Regions-of-interest approach or whole brain approach?
We compared the whole brain approach for SVM classification with an ROI approach using ROIs from a recent meta-analysis on the three variants of PPA (Bisenius et al., 2016) . A similar approach has already been adopted by Dukart and colleagues who compared the whole brain versus ROI approach for SVM classification between FTD and AD as well as between these patient groups and healthy controls using structural MRI and PET scans (Dukart et al., 2013; Dukart et al., 2011) . These authors reported that for MRI scans, the ROI approach was comparable to the whole brain approach for the discrimination between patients and healthy controls, but had a lower accuracy for the discrimination between patient groups (AD vs. FTD) (Dukart et al., 2013; Dukart et al., 2011) . In the current study, the ROI approach reached generally a high accuracy in diagnosis and, at least mainly, differential
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A C C E P T E D M A N U S C R I P T SVM classification for PPA S. Bisenius et al. 24 diagnosis/classification of PPA syndromes, comparable to the whole-brain approach. In detail, it showed a higher accuracy as compared to healthy controls for svPPA patients and a slightly lower accuracy for nfvPPA and lvPPA patients, while it showed a similar accuracy for svPPA vs. nfvPPA and svPPA vs. lvPPA patients as compared to the whole brain approach. Remarkably, for the lvPPA vs.
nfvPPA comparison the ROI approach showed a higher accuracy than the whole brain approach, may be due to the diffusivity and similar strength (in the sense of t-values) of brain atrophy requiring higher regional specificity for the analysis. One might speculate that ROI-based classification might be given preference for special questions in differentiating between syndromes in the future. Given however that none of these trends was statistically significant, we consider both approaches as equally valid.
The visual comparison between the whole brain approach and the ROI approach raises however the question about the optimal method to choose ROIs for SVM classification in PPA. The optimal number of ROIs for SVM classification needs to be such as to accurately capture all subtleties of the structural abnormality in these patients and thus achieve a sufficient predictive accuracy without however reducing predictive accuracy through the increase of noise that possibly accompanies additional ROIs that are less relevant to the classification. Selecting ROIs based on group-level comparison between patients and healthy control groups might for instance provide a higher discriminative power for the SVM classification in the same study sample. These ROIs would however be biased to at least some extent by the specific study sample and might therefore not necessarily lead to similar good results in other study samples. Another possibility to find the optimal ROIs for the SVM classification between nfvPPA (or lvPPA) and healthy controls might consist in rerunning meta-analyses on the three variants of PPA across MRI studies using a less conservative statistical threshold. This methodological approach might no longer exclusively reveal the brain regions that are specific to a given variant (and to some extent possibly even false positive results), but due to the higher sensitivity, also common networks between variants that become usually only visible in longitudinal studies monitoring the progression of the disease (e.g., Rogalski et al., 2011) . For the ROI approach of SVM classification
A C C E P T E D M A N U S C R I P T SVM classification for PPA S. Bisenius et al. 25 between the different variants of PPA, on the other hand, it might be rather promising to only consider ROIs that are either more severely impaired in one variant as in the other variants as for instance the inferior and middle temporal gyri in svPPA, or rather specific to the given variant (e.g., middle frontal gyrus in nfvPPA as compared to svPPA). The considerations regarding the optimal ROI for SVM classification in PPA are however purely hypothetical and need to be investigated in future studies.
Furthermore, it might be interesting to compare the ROI approach to the whole brain approach using combined imaging data as for instance MRI and PET as has already been done for AD and FTD (e.g., Davatzikos et al., 2008b; Dukart et al., 2013; Dukart et al., 2011) or using MRI and diffusion tensor imaging data as has been done by Zhang et al. (2013) , who showed, in a small sample, higher accuracies for whole brain SVM classification of diffusion tensor imaging data than of MRI data for nfvPPA and svPPA versus healthy controls. Moreover, the potential of ROI approaches for disease classification has to be validated in longitudinal studies, where one would assume higher accuracy in early stages.
Limitations
The relatively small number of subjects might hamper the generalization of the results to the overall population of PPA patients. Given however that our results are very similar to another study including more patients but using a different approach (Wilson et al., 2009 ) this should not really constitute a major issue. A problem that might occur in pattern classification methods is the risk of overfitting the data due to the high-dimensionality of the data, which can however be reduced by using the leave-one out approach as has been done in the current study. Segmentation and normalization processes are not always perfect which might result in underestimation of atrophy in patients or underestimation of grey matter in healthy controls, which leads to lower accuracies in the SVM classification. This issue should however at least partly be addressed in the current study given that our data have been acquired on different scanners and were well balanced between patient and healthy control groups.
Finally, the classification between pairs of groups was a highly idealized situation that does not reflect
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Conclusion
Our study aimed at validating the potential of structural multi-center MRI data for disease classification in PPA. We compared the whole brain approach with a disease-specific ROI approach for SVM classification in the three variants of PPA. Generally, both the whole brain and the disease-specific approach reached high classification accuracy in diagnosis and differential diagnosis of PPA syndromes without significant differences. Our results showed that for svPPA, the ROI approach using prototypical disease-related networks as revealed by meta-analyses across MRI studies revealed a higher accuracy (perfect discrimination of 100 %) than the whole brain approach. For nfvPPA and lvPPA on the other hand, the SVM classification showed higher accuracies when using the whole brain approach. The regions contributing to the correct SVM classification of patients mostly corresponded to regions that were consistently atrophied in these patients as shown by the VBM results. For the discrimination between svPPA and nfvPPA, and between svPPA and lvPPA the whole brain approach and the ROI approach showed similar results. The ROI approach increased accuracy in classification between lvPPA and nfvPPA in comparison with the whole brain approach, which might be related to the diffusivity and similar strength (in the sense of t-values) in these PPA syndromes requiring higher regional specificity for the analysis. Given that the accuracies for SVM classification using the ROI approach were still quite high despite the relatively small size of the chosen ROIs as compared to the regions that were taken into account in the whole brain SVM classification of the respective patients, future studies shall further explore the potential of the ROI approach using different ROIs for SVM classification of PPAs. 
Highlights
Aim was to evaluate the potential of multi-center MRI data for individual PPA diagnosis We used support vector machine classification in PPA variants and healthy controls We compared a whole brain approach with a ROI (taken from meta-analyses) approach Accuracies were overall quite high, for both, the whole brain and the ROI approach
